996 filings
Page 3 of 50
CORRESP
8a1qe6l jbx
30 Aug 23
Correspondence with SEC
12:00am
UPLOAD
kcidgsi 0t50h6
28 Aug 23
Letter from SEC
12:00am
4
ds5kk1vijatn66aquqo
24 Aug 23
HERON THERAPEUTICS / Craig A Collard ownership change
4:09pm
8-K
4aldjzbo
14 Aug 23
Heron Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Updates
4:11pm
D
bkqve0u
1 Aug 23
$30.00 mm in equity / options, sold $30.00 mm, 7 investors
1:56pm
4
xy4 uh7kihpeqj
25 Jul 23
HERON THERAPEUTICS / Adam Morgan ownership change
4:22pm
3
zrk3h991ctd5uz2qafr
25 Jul 23
HERON THERAPEUTICS / David Efraim Rosen ownership change
4:15pm
SC 13D/A
uhltgv0mslmhly77o0
25 Jul 23
HERON THERAPEUTICS / Rubric Capital Management ownership change
4:13pm
8-K
fvvsgplzn sn4
24 Jul 23
Heron Therapeutics Announces $30 Million Private Placement Financing
9:12am
4
b88greiohp 1xz3e4isu
19 Jul 23
HERON THERAPEUTICS / Lisa Peraza ownership change
6:21pm
4
5xdjvojp9ejlv6t
17 Jul 23
HERON THERAPEUTICS / David Leslie Szekeres ownership change
5:51pm
4
jhl5ors
17 Jul 23
HERON THERAPEUTICS / Lisa Peraza ownership change
5:51pm
S-8
983b168m2ixmrqck
30 Jun 23
Registration of securities for employees
4:06pm
3
5vh5b ilylf
23 Jun 23
HERON THERAPEUTICS / Ira Duarte ownership change
4:28pm
8-K
qshgc29w9lh wu9
23 Jun 23
Heron Therapeutics Announces Appointment of Ira Duarte as Chief Financial Officer
4:19pm
3
2yzvp
12 Jun 23
HERON THERAPEUTICS / William P Forbes ownership change
4:41pm
8-K
oh72 234uyhafts
12 Jun 23
Heron Therapeutics Announces Appointment of William Forbes, Pharm.D. as Chief Development Officer
9:10am
4
gazzj9
24 May 23
HERON THERAPEUTICS / Craig A Collard ownership change
5:04pm